What Are Cancer Biomarkers and Tumor Markers?

A biomarker is a biological feature that can be measured in tissue, blood, or other body fluids. In cancer care, biomarker testing may look for genes, proteins, or other molecules that can help doctors identify a cancer, estimate how it may behave, or select treatment options.

A tumor marker is a type of biomarker that may be found in blood, tissue, bone marrow, or other body fluids and can sometimes be linked to cancer. However, tumor markers are not always specific to cancer, and some can also be elevated in noncancerous conditions. That is why doctors usually interpret them together with imaging, pathology, symptoms, and other clinical findings.

Why Are These Tests Important in Cancer Care?

Biomarker and tumor marker testing can support care in several ways. Depending on the cancer type, they may help confirm a diagnosis, guide treatment choices, monitor how well therapy is working, or help watch for signs that the disease has returned. Not every marker is useful for every cancer, and not every patient will need the same tests.

This is one reason cancer care has become more individualized. Instead of relying only on where the cancer started in the body, doctors may also look at the tumor’s molecular profile to decide whether a targeted therapy, immunotherapy, or another approach is more appropriate.

Common Ways Biomarkers and Tumor Markers Are Used

Treatment selection

Some biomarkers help doctors match patients to treatments that are more likely to work for their specific cancer. NCI notes that biomarker testing can identify changes in a cancer that may help guide treatment choices.

Monitoring response

In some situations, changes in marker levels over time may help show whether treatment appears to be working, although results must be interpreted carefully and in context.

Detecting recurrence or progression

Certain markers may help doctors watch for signs that a cancer has returned or changed after treatment, especially when used alongside scans and clinical review.

Supporting personalized follow-up

Because cancers can behave differently from one person to another, biomarker information can help shape a more tailored care plan over time.

What Patients Should Know About Test Results

It is natural to assume that a “high” marker automatically means cancer is worsening, but that is not always true. Some tumor markers are not specific, some cancers do not produce useful markers at all, and results can be influenced by other medical factors. This is why doctors usually avoid making major decisions based on a single test result alone.

Patients may also hear about repeat biomarker testing during treatment or after a cancer changes. This can happen because cancers may evolve over time, and updated molecular information can sometimes reveal new treatment opportunities or explain why a therapy is no longer working as expected.